These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12402610)

  • 1. Keeping the catheter exit site clean by sealing with a dressing film in patients under continuous ambulatory peritoneal dialysis.
    Tanaka S; Yosizawa K; Sakuma M
    Adv Perit Dial; 2002; 18():158-60. PubMed ID: 12402610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sealing the catheter exit site with dressing film and its effectiveness in preventing exit-site infection: bacterial culture.
    Tanaka S
    Adv Perit Dial; 1996; 12():214-7. PubMed ID: 8865906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
    Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
    Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
    Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3% Amuchina is as effective as the 50% concentration in the prevention of exit-site infection in children on chronic peritoneal dialysis.
    Grosman MD; Mosquera VM; Hernandez MG; Agostini S; Adragna M; Sojo ET
    Adv Perit Dial; 2005; 21():148-50. PubMed ID: 16686307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
    Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
    Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ultraviolet rays on the prevention of exit-site infections.
    Shimomura A; Tahara D; Tominaga M; Uchigiri S; Yamaguchi Y; Ishioka H; Nakahata A
    Adv Perit Dial; 1995; 11():152-6. PubMed ID: 8534692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new salvage procedure for peritoneal dialysis catheters with exit site infections.
    St Laurent M; Surendranath C; Saad T; Halff G; Esterl R
    Am Surg; 1998 Dec; 64(12):1215-7. PubMed ID: 9843349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Blisterfilm and gauze for peritoneal catheter exit site care.
    Moore CG
    ANNA J; 1989 Dec; 16(7):475-8. PubMed ID: 2604449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis.
    Cavdar C; Atay T; Zeybel M; Celik A; Ozder A; Yildiz S; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():67-70. PubMed ID: 15384798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertonic saline compresses: therapy for complicated exit-site infections.
    Strauss FG; Holmes DL; Nortman DF; Friedman S
    Adv Perit Dial; 1993; 9():248-50. PubMed ID: 8105936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "A change for the better". A nursing innovation for change in the CAPD catheter exit site care.
    Williams J
    EDTNA ERCA J; 1998; 24(2):23-5. PubMed ID: 10392061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
    Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG
    Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once- versus twice-weekly changing of central venous catheter occlusive dressing in intensive chemotherapy patients: results of a randomized multicenter study.
    Vokurka S; Bystricka E; Visokaiova M; Scudlova J
    Med Sci Monit; 2009 Mar; 15(3):CR107-10. PubMed ID: 19247240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cluster of rapidly growing mycobacterial peritoneal dialysis catheter exit-site infections.
    Tse KC; Lui SL; Cheng VC; Yip TP; Lo WK
    Am J Kidney Dis; 2007 Jul; 50(1):e1-5. PubMed ID: 17591517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of hemodialysis central venous catheter exit-site infections.
    Harwood L; Wilson B; Thompson B; Brown E; Young D
    CANNT J; 2008; 18(2):26-35. PubMed ID: 18669009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
    Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
    J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial.
    Luzar MA; Brown CB; Balf D; Hill L; Issad B; Monnier B; Moulart J; Sabatier JC; Wauquier JP; Peluso F
    Perit Dial Int; 1990; 10(1):25-9. PubMed ID: 2085577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for treatment of exit-site and tunnel infections in 177 CAPD patients.
    Bianchessi S; Galimberti E; Belluschi F; Bosaglia M
    EDTNA ERCA J; 1998; 24(2):21-2, 25. PubMed ID: 10392060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.